341 related articles for article (PubMed ID: 15278296)
1. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
Anagnostopoulos A; Galani E; Gika D; Sotou D; Evangelopoulou A; Dimopoulos MA
Ann Hematol; 2004 Oct; 83(10):658-60. PubMed ID: 15278296
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
3. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA
Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal gammopathy of undetermined significance].
Chaïbi P; Merlin L; Thomas C; Piette F
Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
[TBL] [Abstract][Full Text] [Related]
5. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathies and malignancies in patients with chronic urticaria.
Karakelides M; Monson KL; Volcheck GW; Weiler CR
Int J Dermatol; 2006 Sep; 45(9):1032-8. PubMed ID: 16961504
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy in a tertiary referral hospital.
Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
9. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
[TBL] [Abstract][Full Text] [Related]
10. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
Fisher MA; Wilson JR
Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal gammapathy of undetermined significance and autoimmune disease: description of three cases in Senegal].
Diallo S; Ndiaye FS; Pouye A; Lèye A; Touré MA; Diop S; Dièye T; Ka MM; Thiam D; Diakhaté L; Diop TM
Med Trop (Mars); 2008 Feb; 68(1):65-8. PubMed ID: 18478776
[TBL] [Abstract][Full Text] [Related]
12. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
[TBL] [Abstract][Full Text] [Related]
13. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].
Ruiz-Delgado GJ; Gómez Rangel JD
Gac Med Mex; 2004; 140(4):375-9. PubMed ID: 15456147
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of monoclonal gammopathy of undetermined significance.
Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Offord JR; Dispenzieri A; Katzmann JA; Melton LJ
N Engl J Med; 2006 Mar; 354(13):1362-9. PubMed ID: 16571879
[TBL] [Abstract][Full Text] [Related]
16. IgE response in multiple myeloma.
Tamir R; Barchat I; Weiss H; Pick AI
Ann Allergy; 1993 Mar; 70(3):214-7. PubMed ID: 8452316
[TBL] [Abstract][Full Text] [Related]
17. Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance.
Dizdar O; Erman M; Cankurtaran M; Halil M; Ulger Z; Yavuz BB; Ariogul S; Pinar A; Harputluoglu H; Kars A; Celik I
Ann Hematol; 2008 Jan; 87(1):57-60. PubMed ID: 17874101
[TBL] [Abstract][Full Text] [Related]
18. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
19. Presence of crystalline inclusions in the peripheral nerve of a patient with IgA lambda monoclonal gammopathy of undetermined significance.
Vital A; Nedelec-Ciceri C; Vital C
Neuropathology; 2008 Oct; 28(5):526-31. PubMed ID: 18410274
[TBL] [Abstract][Full Text] [Related]
20. Transient paraproteinemia: an intriguing immunological anomaly.
Strobel SL
Ann Clin Lab Sci; 2003; 33(3):265-70. PubMed ID: 12956440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]